Schizophrenia: The drug deadlock

Alison Abbott

Nature, 2010, vol. 468, issue 7321, 158-159

Abstract: The biology is too complicated. Pharma companies are quitting. Where are schizophrenia drugs going to come from?

Date: 2010
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/468158a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:468:y:2010:i:7321:d:10.1038_468158a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/468158a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().